Moleculin Biotech Inc (FRA:MOL)
€ 6.45 0 (0%) Market Cap: 6.66 Mil Enterprise Value: -3.07 Mil PE Ratio: 0 PB Ratio: 0.36 GF Score: 32/100

Moleculin Biotech Inc at HC Wainwright Investment Conference - New York Transcript

Sep 11, 2023 / 11:00AM GMT
Release Date Price: €5.61 (+40.60%)
Jade Montgomery
H.C. Wainwright & Co. - Analyst

Good morning, everyone, and thank you for joining the H.C. Wainwright's 25th Annual Global Investment Conference on September 11 through September 13, 2023. My name is Dr. Jade Montgomery, and I'm part of the biotechnology equity research division here at H.C. Wainwright. We're confident we are going to be able to provide value to you with over 650 companies presenting at this conference in multiple sector tracks devoted to life sciences, cryptocurrency, blockchain and fintech technology, media and telecommunications, cleantech, metals and mining, and growth.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. We have a total of 26 publishing senior analysts and over 643 companies covered across all sectors. Please visit hcwco.com for more information.

(Conference Instructions) With that said, have a productive and enjoyable day. And I'd like to introduce our next presenter. I'd like to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot